# The diverse roles of Hox proteins in the regulation of the cell cycle and their therapeutic value in cancer treatment

**Authors:** Lupeuea Vakafua, Lachlan Clifton-Bligh, Naisana Seyedasli

PMC · DOI: 10.1007/s10555-026-10313-6 · 2026-01-15

## TL;DR

This paper reviews how Hox proteins influence the cell cycle in adult tissues and their potential as cancer treatment targets.

## Contribution

The paper highlights the dual permissive and repressive roles of Hox proteins in the cell cycle and their therapeutic implications in cancer.

## Key findings

- Hox proteins have both permissive and repressive roles in cell cycle regulation in adult tissues.
- Hox proteins are significant as potential therapeutic targets in cancer treatment.
- Understanding Hox gene function and their interactions is crucial for developing effective Hox-targeting therapies.

## Abstract

Tissue morphogenesis and homeostasis occur at the interface of a fine coordination between cell cycle and differentiation events. The fundamental role of Hox genes during embryonic development is well established. However, less is known about their role in adult tissues and in contexts other than cellular differentiation. In this review, we focus on the role of Hox proteins in cell cycle-related events in adult tissues and highlight two main cell cycle-permissive and repressive roles for these genes. Given the significance of Hox proteins as a therapeutic target in cancer treatment, we will further discuss the existing approaches in this domain highlighting the challenges that impact the success prospects. For the successful development and application of Hox-oriented anticancer therapies, a comprehensive image of Hox roles in carcinogenic events including their mechanism of function as well as the networks/cascades within which they exert their effects is an inevitable requirement. Moreover, the functional variations of Hox genes in response to changes in the tumour microenvironment along with possible alternations of the mutational landscape in tumours during disease progression should also be taken into account as factors that might impact the therapeutic outcomes of Hox-targeting approaches.

## Linked entities

- **Genes:** Ho (Heme oxygenase) [NCBI Gene 41407]
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** cancer (MESH:D009369), carcinogenic (MESH:D011230)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12804253/full.md

---
Source: https://tomesphere.com/paper/PMC12804253